Original language | English |
---|---|
Pages (from-to) | 682-687 |
Number of pages | 6 |
Journal | European Urology |
Volume | 78 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2020 |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? / Rhijn, BWG; Mertens, LS; Mayr, R; Bostrom, PJ; Real, FX; Zwarthoff, Ellen; Boormans, Joost; Abas, CS (Cheno); van Leenders, Arno; Gotz, S; Hippe, K; Bertz, S; Neuzillet, Y; Sanders, J; Broeks, A; van der Heijden, MS; Jewett, MAS; Marquez, M; Stoehr, R; Zlotta, AR; Eckstein, M; Soorojebally, Y; Roshani, H; Burger, M; Otto, W; Radvanyi, F; Sirab, N; Pouessel, D; Wullich, B; Kwast, TH; Malats, N; Hartmann, A; Allory, Y; Zuiverloon, Tahlita.
In: European Urology, Vol. 78, No. 5, 2020, p. 682-687.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?
AU - Rhijn, BWG
AU - Mertens, LS
AU - Mayr, R
AU - Bostrom, PJ
AU - Real, FX
AU - Zwarthoff, Ellen
AU - Boormans, Joost
AU - Abas, CS (Cheno)
AU - van Leenders, Arno
AU - Gotz, S
AU - Hippe, K
AU - Bertz, S
AU - Neuzillet, Y
AU - Sanders, J
AU - Broeks, A
AU - van der Heijden, MS
AU - Jewett, MAS
AU - Marquez, M
AU - Stoehr, R
AU - Zlotta, AR
AU - Eckstein, M
AU - Soorojebally, Y
AU - Roshani, H
AU - Burger, M
AU - Otto, W
AU - Radvanyi, F
AU - Sirab, N
AU - Pouessel, D
AU - Wullich, B
AU - Kwast, TH
AU - Malats, N
AU - Hartmann, A
AU - Allory, Y
AU - Zuiverloon, Tahlita
PY - 2020
Y1 - 2020
U2 - 10.1016/j.eururo.2020.07.002
DO - 10.1016/j.eururo.2020.07.002
M3 - Article
VL - 78
SP - 682
EP - 687
JO - European Urology
JF - European Urology
SN - 0302-2838
IS - 5
ER -